Colin Glenn Begley, Chief Scientific Officer & SVP at TETRALOGIC PHARMACEUTICALS CORP (TLOG), bought 1,100 shares at $4.87 ($5K) on 2014-11-26, disclosed to the SEC on 2014-12-01.
Open-market purchase of $5k TLOG by Chief Scientific Officer & SVP. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| TLOG | BUY | 2014-11-28 | $7K | — | Filing → |